Prime Spinal Cord Stimulator Systems News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article
Share this article
MARLBOROUGH, Mass., Jan. 14, 2021 /PRNewswire/ Boston Scientific (NYSE: BSX) has announced a limited market release of the WaveWriter Alpha™ portfolio of Spinal Cord Stimulator (SCS) systems. The unified portfolio of four MRI conditional, Bluetooth-enabled rechargeable and non-rechargeable implantable pulse generators (IPGs) provides uncompromised personalization, and for the first time in SCS, Fast Acting Sub-perception Therapy (FAST™) designed to deliver profound paresthesia-free pain relief in minutes.
i The systems are supported by the Cognita™ Solutions suite of digital tools for patients and physicians.
Patient experience with FAST™
The Next Era of Personalization
The new WaveWriter Alpha™ Spinal Cord Stimulation Systems offer a comprehensive full-body MRI-conditional portfolio, advanced therapies and a suite of digital solutions for physicians and patients with chronic pain. ....

United States , Maulik Nanavaty , Wavewriter Alpha , Rochelle Silsbee , Susie Lisa , Boston Scientific Corporation , Us Department Of Health , Human Services , Cognita Solutions , Boston Scientific , Exchange Commission , Securities Exchange , Agency Task Force , Duke University , Drug Administration , Securities Act , Securities Exchange Act , Risk Factors , Annual Report , Quarterly Reports , Prime Spinal Cord Stimulator Systems , Body Guidelines , Prime Spinal Cord Stimulator , ஒன்றுபட்டது மாநிலங்களில் , ம Ul லிக் நானாவதி , ரோசெல் சில்ஸ்பீ ,